USD0.000æéå€ååŒÂ  (ET)
40.77BæäŸ¡ç·é¡
28.42çŽè¿12ã¶æPER
Teva Pharmaceutical Industries Ltd
äž»èŠããŒã¿
35.605å§å€
35.660é«å€
4.70Måºæ¥é«
28.42çŽè¿12ã¶æPER
11.22äºæ³PER
--çŽè¿12ã¶æé
åœ
0.40%売買å転ç
35.410忥çµå€
34.560å®å€
77.80M売買代é
æå€±é¡æ ªäŸ¡åçç
5.26PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
3.99%ç·è³ç£å©çç
37.34552é±é«å€
0.59åºæ¥é«æ¯ç%
-1.64BçŽå©ç
1.17Bæ ªåŒæ°
1.23141æ ªåœããå©çïŒEPSïŒ
0.84ããŒã¿å€
21.60%èªå·±è³æ¬å©çç
14.99052é±å®å€
3.11%æ¯ãå¹
52.29%ç²å©çç
40.77BæäŸ¡ç·é¡
1.22ãªã¹ã¯ãªã¿ãŒã³
1.82%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Teva Pharmaceutical Industries Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž82äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯38.93ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Teva Pharmaceutical Industries Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Teva Pharmaceutical Industries Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Teva Pharmaceutical Industries Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Teva Pharmaceutical Industries Ltd
TEVA
12
ææšî
ææš
売ã(1)
äžç«(2)
è²·ã(2)
ç§»åå¹³å
売ã(0)
äžç«(0)
è²·ã(6)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Teva Pharmaceutical Industries Ltdã®äŒæ¥æ
å ±î
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
äŒæ¥ã³ãŒãTEVA
äŒæ¥åTeva Pharmaceutical Industries Ltd
æé«çµå¶è²¬ä»»è
ãCEOãFrancis (Richard D)
ãŠã§ããµã€ãhttps://www.tevapharm.com/
æ ªäž»çµ±èšî
ãããã質å
Teva Pharmaceutical Industries LtdïŒTEVAïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îTeva Pharmaceutical Industries LtdïŒTEVAïŒã®çŸåšã®æ ªäŸ¡ã¯35.00ã§ãã
Teva Pharmaceutical Industries Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îTeva Pharmaceutical Industries Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯TEVAã§ãã
Teva Pharmaceutical Industries Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îTeva Pharmaceutical Industries Ltdã®52é±é«å€ã¯37.34ã§ãã
Teva Pharmaceutical Industries Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îTeva Pharmaceutical Industries Ltdã®52é±å®å€ã¯14.99ã§ãã
Teva Pharmaceutical Industries Ltdã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îTeva Pharmaceutical Industries Ltdã®æäŸ¡ç·é¡ã¯40.77Bã§ãã
Teva Pharmaceutical Industries Ltd (TEVA) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãTeva Pharmaceutical Industries LtdïŒTEVAïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯38.93ã§ãã
Teva Pharmaceutical Industries Ltd (TEVA) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îTeva Pharmaceutical Industries LtdïŒTEVAïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯1.23ã§ãã